These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 30145859)
1. [Hyponatremia in Liver Cirrhosis]. Jang CM; Jung YK Korean J Gastroenterol; 2018 Aug; 72(2):74-78. PubMed ID: 30145859 [TBL] [Abstract][Full Text] [Related]
2. Hyponatremia in cirrhosis: pathophysiology and management. John S; Thuluvath PJ World J Gastroenterol; 2015 Mar; 21(11):3197-205. PubMed ID: 25805925 [TBL] [Abstract][Full Text] [Related]
3. Hyponatremia in Cirrhosis: An Update. Alukal JJ; John S; Thuluvath PJ Am J Gastroenterol; 2020 Nov; 115(11):1775-1785. PubMed ID: 33156095 [TBL] [Abstract][Full Text] [Related]
4. Hypervolemic Hyponatremia (Liver). Solà E; Ginès P Front Horm Res; 2019; 52():104-112. PubMed ID: 32097916 [TBL] [Abstract][Full Text] [Related]
5. Association between the Serum Sodium Levels and the Response to Tolvaptan in Liver Cirrhosis Patients with Ascites and Hyponatremia. Hayashi M; Abe K; Fujita M; Okai K; Takahashi A; Ohira H Intern Med; 2018 Sep; 57(17):2451-2458. PubMed ID: 29607963 [TBL] [Abstract][Full Text] [Related]
6. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. Arroyo V; Jiménez W J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802 [TBL] [Abstract][Full Text] [Related]
8. The kidney in cirrhosis with portal hypertension. Olteanu D; Lupu D J Med Life; 2010; 3(2):175-7. PubMed ID: 20968204 [TBL] [Abstract][Full Text] [Related]
9. Hyponatremia in Cirrhosis: Implications for Liver Transplantation. Leise M; Cárdenas A Liver Transpl; 2018 Nov; 24(11):1612-1621. PubMed ID: 30129266 [TBL] [Abstract][Full Text] [Related]
10. The management of ascites and hyponatremia in cirrhosis. Ginès P; Cárdenas A Semin Liver Dis; 2008 Feb; 28(1):43-58. PubMed ID: 18293276 [TBL] [Abstract][Full Text] [Related]
11. Hyponatremia in cirrhosis: clinical features and management. Martín-Llahí M; Guevara M; Ginès P Gastroenterol Clin Biol; 2006 Oct; 30(10):1144-51. PubMed ID: 17075468 [TBL] [Abstract][Full Text] [Related]
12. [Refractory ascites and dilutional hyponatremia: current management and new aquaretics]. Torre Delgadillo A Rev Gastroenterol Mex; 2005; 70(3):299-311. PubMed ID: 17063787 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiology of ascites and dilutional hyponatremia: contemporary use of aquaretic agents. Leiva JG; Salgado JM; Estradas J; Torre A; Uribe M Ann Hepatol; 2007; 6(4):214-21. PubMed ID: 18007550 [TBL] [Abstract][Full Text] [Related]
17. Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V₂-receptor antagonist tolvaptan. Gaglio P; Marfo K; Chiodo J Dig Dis Sci; 2012 Nov; 57(11):2774-85. PubMed ID: 22732834 [TBL] [Abstract][Full Text] [Related]
18. Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report. Parekh A; Rajaram P; Patel G; Subramanian RM Transplant Proc; 2017 Dec; 49(10):2399-2401. PubMed ID: 29198689 [TBL] [Abstract][Full Text] [Related]
19. [Vasopressin antagonists in treatment of hyponatremia]. Olszewski W; Głuszek J Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383 [TBL] [Abstract][Full Text] [Related]
20. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Ginès P; Guevara M Hepatology; 2008 Sep; 48(3):1002-10. PubMed ID: 18671303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]